Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vaccine ; 40(43): 6255-6270, 2022 10 12.
Artigo em Inglês | MEDLINE | ID: mdl-36137904

RESUMO

Swine influenza A virus (swIAV) infections in pig populations cause considerable morbidity and economic losses. Frequent reverse zoonotic incursions of human IAV boost reassortment opportunities with authentic porcine and avian-like IAV in swine herds potentially enhancing zoonotic and even pre-pandemic potential. Vaccination using adjuvanted inactivated full virus vaccines is frequently used in attempting control of swIAV infections. Accelerated antigenic drift of swIAV in large swine holdings and interference of maternal antibodies with vaccine in piglets can compromise these efforts. Potentially more efficacious modified live-attenuated vaccines (MLVs) bear the risk of reversion of MLV to virulence. Here we evaluated new MLV candidates based on cold-passaged swIAV or on reassortment-incompetent bat-IAV-swIAV chimeric viruses. Serial cold-passaging of various swIAV subtypes did not yield unambiguously temperature-sensitive mutants although safety studies in mice and pigs suggested some degree of attenuation. Chimeric bat-swIAV expressing the hemagglutinin and neuraminidase of an avian-like H1N1, in contrast, proved to be safe in mice and pigs, and a single nasal inoculation induced protective immunity against homologous challenge in pigs. Reassortant-incompetent chimeric bat-swIAV vaccines could aid in reducing the amount of swIAV circulating in pig populations, thereby increasing animal welfare, limiting economic losses and lowering the risk of zoonotic swIAV transmission.


Assuntos
Quirópteros , Vírus da Influenza A Subtipo H1N1 , Vírus da Influenza A , Vacinas contra Influenza , Influenza Humana , Infecções por Orthomyxoviridae , Doenças dos Suínos , Animais , Anticorpos Antivirais , Hemaglutininas , Humanos , Influenza Humana/prevenção & controle , Camundongos , Neuraminidase/genética , Vírus Reordenados/genética , Suínos , Vacinas Atenuadas , Vacinas de Produtos Inativados
2.
Vet Res ; 42: 97, 2011 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-21878124

RESUMO

A mysterious disease affecting calves, named bovine neonatal pancytopenia (BNP), emerged in 2007 in several European countries. Epidemiological studies revealed a connection between BNP and vaccination with an inactivated vaccine against bovine virus diarrhea (BVD). Alloantibodies reacting with blood leukocytes of calves were detected in serum and colostrum of dams, which have given birth to calves affected by BNP. To understand the linkage between vaccination and the development of alloantibodies, we determined the antigens reacting with these alloantibodies. Immunoprecipitation of surface proteins from bovine leukocytes and kidney cells using sera from dams with a confirmed case of BNP in their gestation history reacted with two dominant protein species of 44 and 12 kDa. These proteins were not detected by sera from dams, free of BVDV and not vaccinated against BVD, and from sera of animals vaccinated with a different inactivated BVD vaccine. The 44 kDa protein was identified by mass spectrometry analysis as MHC I, the other as ß-2-microglobulin. The presence of major histocompatibility complex class I (MHC I) in the vaccine was confirmed by Western blot using a MHC I specific monoclonal antibody. A model of BNP pathogenesis is proposed.


Assuntos
Doença das Mucosas por Vírus da Diarreia Viral Bovina/imunologia , Doenças dos Bovinos/imunologia , Vírus da Diarreia Viral Bovina/imunologia , Pancitopenia/veterinária , Vacinas Virais/imunologia , Sequência de Aminoácidos , Animais , Animais Recém-Nascidos , Anticorpos Antivirais/sangue , Antígenos Virais/sangue , Western Blotting/veterinária , Doença das Mucosas por Vírus da Diarreia Viral Bovina/virologia , Bovinos , Doenças dos Bovinos/virologia , Colostro/metabolismo , Feminino , Antígenos de Histocompatibilidade Classe I/química , Antígenos de Histocompatibilidade Classe I/genética , Antígenos de Histocompatibilidade Classe I/metabolismo , Imunoprecipitação/veterinária , Isoanticorpos/sangue , Rim/imunologia , Rim/virologia , Leucócitos/imunologia , Leucócitos/virologia , Espectrometria de Massas/veterinária , Pancitopenia/imunologia , Pancitopenia/virologia , Mapeamento de Peptídeos/veterinária , Vacinas de Produtos Inativados/administração & dosagem , Vacinas de Produtos Inativados/imunologia , Vacinas Virais/administração & dosagem , Microglobulina beta-2/química , Microglobulina beta-2/genética , Microglobulina beta-2/metabolismo
3.
J Mass Spectrom ; 46(6): 568-71, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21630385

RESUMO

The work presented in this report describes and demonstrates a protocol for protein imaging analysis of biological tissue using MALDI IMS where histological staining and MS analysis are performed on the same tissue section. Spatial image resolution is shown at 35 µm for sagittal sections of the cerebellum from rat brain.


Assuntos
Histocitoquímica/métodos , Imagem Molecular/métodos , Proteínas do Tecido Nervoso/química , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Animais , Cerebelo/química , Feminino , Técnicas de Preparação Histocitológica , Masculino , Proteínas do Tecido Nervoso/análise , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...